Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Chemical Communications (Cambridge, England)
|
October 21, 2011
One-pot reduction of graphene oxide at subzero temperatures
Peng Cui, Junghyun Lee, Eunhee Hwang, et al.
Scientific Reports
|
September 15, 2016
Mesoporous Non-stacked Graphene-receptor Sensor for Detecting Nerve Agents
Hee Min Hwang, Eunhee Hwang, Doyoung Kim, et al.
The Primary Care Companion for CNS Disorders
|
December 23, 2015
Efficacy of Desvenlafaxine 50 mg/d Versus Placebo in the Long-Term Treatment of Major Depressive Disorder: A Randomized, Double-Blind Trial
Patrice Boyer, Cécile Vialet, Eunhee Hwang, et al.
Angewandte Chemie (International Ed. in English)
|
August 10, 2017
Functional Molecular Junctions Derived from Double Self-Assembled Monolayers
Sohyeon Seo, Eunhee Hwang, Yunhee Cho, et al.
Chemical Communications (Cambridge, England)
|
March 24, 2012
Nonvolatile resistive memory of ferrocene covalently bonded to reduced graphene oxide
Changhua Jin, Junghyun Lee, Eunkyo Lee, et al.
BMC Psychiatry
|
March 23, 2013
A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder
Michael R Liebowitz, Karen A Tourian, Eunhee Hwang, et al.
Chemical Communications (Cambridge, England)
|
June 28, 2012
Binol salt as a completely removable graphene surfactant
Surajit Some, Youngmin Kim, EunHee Hwang, et al.
Menopause (New York, N.Y.)
|
September 27, 2012
Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial
JoAnn V Pinkerton, Ginger Constantine, Eunhee Hwang, et al.
Journal of Psychiatric Practice
|
January 22, 2013
Efficacy and safety of desvenlafaxine 25 and 50▒mg/day in a randomized, placebo-controlled study of depressed outpatients
Nakao Iwata, Karen A Tourian, Eunhee Hwang, et al.
The Journal of Clinical Psychiatry
|
March 12, 2013
Efficacy and safety of desvenlafaxine 50 mg/d for prevention of relapse in major depressive disorder:a randomized controlled trial
Joshua Z Rosenthal, Patrice Boyer, Cécile Vialet, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Chemical Communications (Cambridge, England)
|
October 21, 2011
One-pot reduction of graphene oxide at subzero temperatures
Peng Cui, Junghyun Lee, Eunhee Hwang, et al.
Scientific Reports
|
September 15, 2016
Mesoporous Non-stacked Graphene-receptor Sensor for Detecting Nerve Agents
Hee Min Hwang, Eunhee Hwang, Doyoung Kim, et al.
The Primary Care Companion for CNS Disorders
|
December 23, 2015
Efficacy of Desvenlafaxine 50 mg/d Versus Placebo in the Long-Term Treatment of Major Depressive Disorder: A Randomized, Double-Blind Trial
Patrice Boyer, Cécile Vialet, Eunhee Hwang, et al.
Angewandte Chemie (International Ed. in English)
|
August 10, 2017
Functional Molecular Junctions Derived from Double Self-Assembled Monolayers
Sohyeon Seo, Eunhee Hwang, Yunhee Cho, et al.
Chemical Communications (Cambridge, England)
|
March 24, 2012
Nonvolatile resistive memory of ferrocene covalently bonded to reduced graphene oxide
Changhua Jin, Junghyun Lee, Eunkyo Lee, et al.
BMC Psychiatry
|
March 23, 2013
A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder
Michael R Liebowitz, Karen A Tourian, Eunhee Hwang, et al.
Chemical Communications (Cambridge, England)
|
June 28, 2012
Binol salt as a completely removable graphene surfactant
Surajit Some, Youngmin Kim, EunHee Hwang, et al.
Menopause (New York, N.Y.)
|
September 27, 2012
Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial
JoAnn V Pinkerton, Ginger Constantine, Eunhee Hwang, et al.
Journal of Psychiatric Practice
|
January 22, 2013
Efficacy and safety of desvenlafaxine 25 and 50▒mg/day in a randomized, placebo-controlled study of depressed outpatients
Nakao Iwata, Karen A Tourian, Eunhee Hwang, et al.
The Journal of Clinical Psychiatry
|
March 12, 2013
Efficacy and safety of desvenlafaxine 50 mg/d for prevention of relapse in major depressive disorder:a randomized controlled trial
Joshua Z Rosenthal, Patrice Boyer, Cécile Vialet, et al.
Page
of 4